-
-
Scenario: The lead II rhythm strip shown above was observed on telemetry. Is the patient in atrial flutter?
-
The FDA has approved an ethyl ester of eicosapentaenoic acid (EPA) to treat hypertriglyceridemia. It is the second drug in this class after Lovaza, which contains esters of both EPA and DHA (docosahexaenoic acid). Icosapent ethyl is marketed by Amarin Pharmaceuticals, a Dublin, Ireland-based company, as Vascepa.
-
Nightly melatonin improved objective and subjective sleep quality in a small number of patients who were taking beta-blockers for hypertension.
-
A modified recombinant human granulocyte colony-stimulating factor (G-CSF) has been approved by the FDA.
-
In a prospectively followed cohort of obese, non-diabetic men and women from Sweden, individuals who underwent bariatric surgery had an 83% reduction in the risk of developing type 2 diabetes over 15 years of follow-up.
-
Three common medications amitripty-line, duloxetine, and pregabalin all appear equally efficacious in treating neuropathic pain from diabetic neuropathy.
-
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
There has long been an appreciation of the risk of cognitive decline associated with chemotherapy but questions remain about the magnitude and duration of the observed deficits. In this meta-analysis of studies that included neuropsychological assessments at a minimum of 6 months after completion of breast cancer chemotherapy, definite but small deficits were found for both verbal and visuospatial capabilities.
-
Sexually transmitted diseases (STDs) are frequently encountered in clinical medicine. According to the Centers for Disease Control, approximately 2.8 million infections with Chlamydia trachomatis1 and 700,000 infections with Neisseria gonorrhea2 occur annually in the United States. Viral sexually transmitted diseases are frequently incurable, so prevalence data are a better measure of the overall burden of disease.